Life Sciences
LivEndocrine, LLC
Year
2021
LivEndocrine is developing new pharmaceutical treatments for Type II diabetes.
Website
Company Status
Active
U of A Inventors
Benjamin Renquist
Caroline Geisler
College
College of Agriculture and Life Sciences